Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Identifying driver genes in head and neck squamous cell carcinoma using an in vivo CRISPR-activation screen

FY 2022-23

Summary
Novel sequencing technologies have been revolutionary in uncovering genetic alterations within deadly head and neck cancers. However, despite this intricate knowledge of sequence alterations in these tumours, we still do not know what causes the cancer to grow, metastasize, and eventually kill the patients. Delineating genes responsible for tumour development is at the heart of cancer research and could identify novel drug targets. Conventional methods to find these genes usually rely on studying cells in a culture dish. However, these methods do not mimic what tumour cells experience in their native environment within a patient, thus limiting the discovery of driver genes and potential therapeutics. For example, driver genes that allow a tumour to evade killing by the immune system can never be interrogated in a culture dish, which lacks all immune components. Here, I aim to generate a system that allows me to test hundreds of alterations in a novel model of head and neck cancer. I will generate viral particles that carry a gene editing tool programmed to activate specific target genes. These viral particles will be injected into mouse embryos, allowing for infection and gene activation to occur within distinct patches of the skin, mouth, and throat. If one of these targets is an oncogene, its activation will trigger tumour formation. Through sequencing the viral cargo within each tumour, I can map back the gene that caused tumour growth. This model overcomes limitations of previous systems, as large numbers of genes and their functions can be simultaneously assessed in the context of their native environment. Through my work, we will gain new insights into the mechanisms of head and neck tumour development and potentially reveal therapeutic targets within the cancer.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
485982
Name
Nurtanto Jocelyn
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identifying driver genes in head and neck squamous cell carcinoma using an in vivo CRISPR-activation screen
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Copy Number Alterations; Crispr-A; Hnscc; Screening; Tumorigenesis
Abstract
Novel sequencing technologies have been revolutionary in uncovering genetic alterations within deadly head and neck cancers. However, despite this intricate knowledge of sequence alterations in these tumours, we still do not know what causes the cancer to grow, metastasize, and eventually kill the patients. Delineating genes responsible for tumour development is at the heart of cancer research and could identify novel drug targets. Conventional methods to find these genes usually rely on studying cells in a culture dish. However, these methods do not mimic what tumour cells experience in their native environment within a patient, thus limiting the discovery of driver genes and potential therapeutics. For example, driver genes that allow a tumour to evade killing by the immune system can never be interrogated in a culture dish, which lacks all immune components. Here, I aim to generate a system that allows me to test hundreds of alterations in a novel model of head and neck cancer. I will generate viral particles that carry a gene editing tool programmed to activate specific target genes. These viral particles will be injected into mouse embryos, allowing for infection and gene activation to occur within distinct patches of the skin, mouth, and throat. If one of these targets is an oncogene, its activation will trigger tumour formation. Through sequencing the viral cargo within each tumour, I can map back the gene that caused tumour growth. This model overcomes limitations of previous systems, as large numbers of genes and their functions can be simultaneously assessed in the context of their native environment. Through my work, we will gain new insights into the mechanisms of head and neck tumour development and potentially reveal therapeutic targets within the cancer.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nurtanto, Jocelyn
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~